Cargando…

Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease

BACKGROUND: Cerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alteration...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yachen, Zhao, En, Li, Lei, Zhao, Songyun, Mao, Haixia, Deng, Jingyu, Ji, Wei, Li, Yang, Gao, Qianqian, Zeng, Siyuan, Ma, Lin, Xi, Guangjun, You, Yiping, Shao, Junfei, Fang, Xiangming, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366612/
https://www.ncbi.nlm.nih.gov/pubmed/37496806
http://dx.doi.org/10.3389/fcimb.2023.1231541
_version_ 1785077205425979392
author Shi, Yachen
Zhao, En
Li, Lei
Zhao, Songyun
Mao, Haixia
Deng, Jingyu
Ji, Wei
Li, Yang
Gao, Qianqian
Zeng, Siyuan
Ma, Lin
Xi, Guangjun
You, Yiping
Shao, Junfei
Fang, Xiangming
Wang, Feng
author_facet Shi, Yachen
Zhao, En
Li, Lei
Zhao, Songyun
Mao, Haixia
Deng, Jingyu
Ji, Wei
Li, Yang
Gao, Qianqian
Zeng, Siyuan
Ma, Lin
Xi, Guangjun
You, Yiping
Shao, Junfei
Fang, Xiangming
Wang, Feng
author_sort Shi, Yachen
collection PubMed
description BACKGROUND: Cerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alterations lead to cerebrovascular disease pathogenesis. The current study aims to determine the alteration and clinical value of the gut microbiota in CSVD patients. METHODS: Sixty-four CSVD patients and 18 matched healthy controls (HCs) were included in our study. All the participants underwent neuropsychological tests, and the multi-modal magnetic resonance imaging depicted the changes in brain structure and function. Plasma samples were collected, and the fecal samples were analyzed with 16S rRNA gene sequencing. RESULTS: Based on the alpha diversity analysis, the CSVD group had significantly decreased Shannon and enhanced Simpson compared to the HC group. At the genus level, there was a significant increase in the relative abundances of Parasutterella, Anaeroglobus, Megasphaera, Akkermansia, Collinsella, and Veillonella in the CSVD group. Moreover, these genera with significant differences in CSVD patients revealed significant correlations with cognitive assessments, plasma levels of the blood-brain barrier-/inflammation-related indexes, and structural/functional magnetic resonance imaging changes. Functional prediction demonstrated that lipoic acid metabolism was significantly higher in CSVD patients than HCs. Additionally, a composite biomarker depending on six gut microbiota at the genus level displayed an area under the curve of 0.834 to distinguish CSVD patients from HCs using the least absolute shrinkage and selection operator (LASSO) algorithm. CONCLUSION: The evident changes in gut microbiota composition in CSVD patients were correlated with clinical features and pathological changes of CSVD. Combining these gut microbiota using the LASSO algorithm helped identify CSVD accurately.
format Online
Article
Text
id pubmed-10366612
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103666122023-07-26 Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease Shi, Yachen Zhao, En Li, Lei Zhao, Songyun Mao, Haixia Deng, Jingyu Ji, Wei Li, Yang Gao, Qianqian Zeng, Siyuan Ma, Lin Xi, Guangjun You, Yiping Shao, Junfei Fang, Xiangming Wang, Feng Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Cerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alterations lead to cerebrovascular disease pathogenesis. The current study aims to determine the alteration and clinical value of the gut microbiota in CSVD patients. METHODS: Sixty-four CSVD patients and 18 matched healthy controls (HCs) were included in our study. All the participants underwent neuropsychological tests, and the multi-modal magnetic resonance imaging depicted the changes in brain structure and function. Plasma samples were collected, and the fecal samples were analyzed with 16S rRNA gene sequencing. RESULTS: Based on the alpha diversity analysis, the CSVD group had significantly decreased Shannon and enhanced Simpson compared to the HC group. At the genus level, there was a significant increase in the relative abundances of Parasutterella, Anaeroglobus, Megasphaera, Akkermansia, Collinsella, and Veillonella in the CSVD group. Moreover, these genera with significant differences in CSVD patients revealed significant correlations with cognitive assessments, plasma levels of the blood-brain barrier-/inflammation-related indexes, and structural/functional magnetic resonance imaging changes. Functional prediction demonstrated that lipoic acid metabolism was significantly higher in CSVD patients than HCs. Additionally, a composite biomarker depending on six gut microbiota at the genus level displayed an area under the curve of 0.834 to distinguish CSVD patients from HCs using the least absolute shrinkage and selection operator (LASSO) algorithm. CONCLUSION: The evident changes in gut microbiota composition in CSVD patients were correlated with clinical features and pathological changes of CSVD. Combining these gut microbiota using the LASSO algorithm helped identify CSVD accurately. Frontiers Media S.A. 2023-07-11 /pmc/articles/PMC10366612/ /pubmed/37496806 http://dx.doi.org/10.3389/fcimb.2023.1231541 Text en Copyright © 2023 Shi, Zhao, Li, Zhao, Mao, Deng, Ji, Li, Gao, Zeng, Ma, Xi, You, Shao, Fang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Shi, Yachen
Zhao, En
Li, Lei
Zhao, Songyun
Mao, Haixia
Deng, Jingyu
Ji, Wei
Li, Yang
Gao, Qianqian
Zeng, Siyuan
Ma, Lin
Xi, Guangjun
You, Yiping
Shao, Junfei
Fang, Xiangming
Wang, Feng
Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
title Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
title_full Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
title_fullStr Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
title_full_unstemmed Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
title_short Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
title_sort alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366612/
https://www.ncbi.nlm.nih.gov/pubmed/37496806
http://dx.doi.org/10.3389/fcimb.2023.1231541
work_keys_str_mv AT shiyachen alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT zhaoen alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT lilei alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT zhaosongyun alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT maohaixia alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT dengjingyu alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT jiwei alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT liyang alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT gaoqianqian alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT zengsiyuan alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT malin alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT xiguangjun alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT youyiping alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT shaojunfei alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT fangxiangming alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease
AT wangfeng alterationandclinicalpotentialingutmicrobiotainpatientswithcerebralsmallvesseldisease